Assessment and Cost Analysis for Patients Admitted to Emergency Department with Macroscopic Hematuria

Basit Öğe Kaydı
dc.contributor.authorSonmez, Leyla Ozturk
dc.contributor.authorTuraliev, Nurmanbet
dc.contributor.authorAyranci, Mustafa Kursat
dc.contributor.authorOzturk, Esma Erdemir
dc.contributor.authorAydin, Arif
dc.date.accessioned2024-02-23T14:38:08Z
dc.date.available2024-02-23T14:38:08Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstractAim: This study examined the etiological causes and their cost analysis in patients admitted and hospitalized with macroscopic hematuria (MH).Materials and Methods: Hemograms, urine, and biochemistry results of patients with MH, radiological images and pathology results, hospitalization need, hospitalization durations, and hematuria causes acquired following hospitalization, and the expenditures during this phase were registered for the patients. Laboratory values for the detected hematuria causes were compared and examined statistically.Results: Seventy-eight patients admitted to the emergency department with MH were evaluated. The most common underlying pathologies were bladder cancer (34.6%, n=27), prostate pathologies (24.3%, n=19), kidney stone (8.9%, n=7), urethral stone (7.7%, n=6), kidney cancer (7.7%, n=6), bladder stone (6.4%, n=5), urinary infection (6.4%, n=5), kidney laceration (2.6%, n=2) and arteriovenous malformation (1.3%, n=1) respectively. The mean invoice amount covering the management starting from admission with MH was 6647 +/- 10200 for each patient. In operated patients (n=54), hospitalization duration, catheterization duration, and invoice amount were found to be higher; in patients with malignancy (n=34) age, hospitalization duration, catheterization duration, and invoice amount were higher (p<0.05, all parameters).Conclusion: Among patients with MH, those with indications for surgery and malignancy have a greater impact on health expenditure. We can conclude that it will be beneficial for both the patient and the economy to start the diagnosis and treatment process before the onset of MH with prevention and early screening workups.en_US
dc.identifier.doi10.4274/eajem.galenos.2023.57615
dc.identifier.endpage189en_US
dc.identifier.issn2149-5807
dc.identifier.issn2149-6048
dc.identifier.issue3en_US
dc.identifier.startpage183en_US
dc.identifier.urihttps://doi.org/10.4274/eajem.galenos.2023.57615
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16363
dc.identifier.volume22en_US
dc.identifier.wosWOS:001115771500010en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofEurasian Journal Of Emergency Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCanceren_US
dc.subjectHematuriaen_US
dc.subjectMalignancyen_US
dc.subjectOperationen_US
dc.subjectUrolithiasisen_US
dc.titleAssessment and Cost Analysis for Patients Admitted to Emergency Department with Macroscopic Hematuriaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu